Work

Evaluation of the novel “trial within a trial” design of METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in patients (pts) with advanced renal cell carcinoma (RCC)

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw373.42

Authors: C. Hessel, M. Mangeshkar, R.J. Motzer, B. Escudier, T.B. Powles, G. Schwab, T.K. Choueiri

Institutions: Exelixis (United States), Memorial Sloan Kettering Cancer Center, Institut Gustave Roussy, Queen Mary University of London, Barts Cancer Institute, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2587423593

FWCI:

Cites:

Cited by:

Related to: 10